- High efficacy of combined rituximab and gemcitabine on Epstein-Barr virus-associated human B-cell lymphoma obtained after Hodgkin's xenograft in immunodeficient mice. Decaudin, D., Marszak, F.B., Couturier, J., Mathiot, C., Martin, A., Némati, F., Lantz, O., Santo, J., Arnaud, P., Bordier, V., Vincent-Salomon, A., Poupon, M.F. Anticancer Drugs (2006)